Lixisenatide as add-on therapy to basal insulin
Many patients with type 2 diabetes mellitus do not achieve target glycosylated hemoglobin A1c levels despite optimally titrated basal insulin and satisfactory fasting plasma glucose levels. Current evidenc...
PubMed Central (PMC)